Retigabine Dihydrochloride
- Catalog NO.:A851340
- CAS No. : 150812-13-8
- Molecular Formula:C16H20Cl2FN3O2
- Molecular Weight: 376.25
Note*
1. Please click the to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Bulk Inquiry
1. Please click the to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Quality Control&SDS
Product Details
CAS Number | 150812-13-8 | Appearance | |
Catalog Number | A851340 | MDL Number | |
Molecular Formula | C16H20Cl2FN3O2 | Molecular Weight | 376.25 |
Boiling Point | Melting Point | ||
Flash Point | Density | ||
Synonyms | ethyl 4-(4-fluorobenzylamino)-2-aminophenylcarbamate dihydrochloride | ||
Storage Condition | Store in a tightly closed container,in a cool and dry place |
Safety
GHS Pictogram | |||
Signal Word | Warning | UN Number | |
Hazard Statements | Class | ||
Precautionary Statements | Packing Group |
Description
Ezogabine, also known as Retigabine, is an anticonvulsant used as an adjunctive treatment for partial epilepsies in treatment-experienced adult patients. The drug was developed by Valeant Pharmaceuticals and GlaxoSmithKline. Ezogabine works primarily as a potassium channel opener—that is, by activating a certain family of voltage-gated potassium channels in the brain. This mechanism of action is unique among antiepileptic drugs, and may hold promise for the treatment of other neurologic conditions, including migraine, tinnitus and neuropathic pain. |